ロード中...

Advertisement

Alvotech Partners Dr. Reddy's To Bring AVT03 Biosimilar To Prolia & Xgeva To U.S., Europe, And U.K

RTTNews | 490日前

Alvotech Partners Dr. Reddy's To Bring AVT03 Biosimilar To Prolia & Xgeva To U.S., Europe, And U.K

(RTTNews) - Biotech company Alvotech (ALVO) and Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. (RDY), announced Tuesday that the companies have entered into a license and supply agreement for the commercialization of AVT03, Alvotech's biosimilar candidate to Prolia and Xgeva (denosumab).

The collaboration combines Dr. Reddy's global commercial presence with Alvotech's proven capabilities in developing biosimilars for markets worldwide.

Prolia and Xgeva are indicated for the treatment of various diseases including osteoporosis in postmenopausal women and prevention of skeletal-related events in adults with advanced malignancies.

Alvotech will be responsible for development and manufacturing of the product, while Dr. Reddy's will be responsible for registration and commercialization of the product in the applicable markets.

The license and supply agreement includes an upfront payment to Alvotech, with additional payments upon certain regulatory and commercialization milestones as well as sales-based payments.

Dr. Reddy's commercialization rights are exclusive for the U.S., and semi-exclusive for Europe and the UK.

タグ: ALVO

read more

OECD Warns Full Effects Of High U.S. Tariffs Yet To Be Felt

OECD Warns Full Effects Of High U.S. Tariffs Yet To Be Felt

The Organisation for Economic Co-operation and Development said in a report on Tuesday that the full impact of the massive hike in trade tariffs announced by the U.S. is yet to be felt though early effects are becoming increasingly evident.

RTTNews | 1時6分前

TSX Retreats After Sailing Past 30k Mark For First Ever Time

TSX Retreats After Sailing Past 30k Mark For First Ever Time

Canadian benchmark S&P/TSX Composite Index breached the 30k mark for the first ever time, and moved on to a new high Tuesday morning before paring gains and slipping into negative territory, due largely to profit taking.

RTTNews | 3時32分前

Swiss Market Ends Marginally Down

Swiss Market Ends Marginally Down

The Switzerland market closed on a weak note on Tuesday after a choppy ride as stocks turned in a mixed performance.

RTTNews | 4時4分前

European Stocks Close Broadly Higher

European Stocks Close Broadly Higher

European markets closed mostly higher on Tuesday with investors digesting the latest batch of regional economic data, and picking up stocks amid expectations of more monetary easing by the Federal Reserve.

RTTNews | 4時24分前

Powell Warns There's 'No Risk-Free Path' For Interest Rates

Powell Warns There's 'No Risk-Free Path' For Interest Rates

Following last week's decision to cut interest rates for the first time this year, Federal Reserve Chair Jerome Powell delivered remarks before the 2025 Greater Providence Chamber of Commerce Economic Outlook Luncheon in Warwick, Rhode Island, on Tuesday.

RTTNews | 4時58分前

Hungary Holds Rates Steady As Inflation Expected To Remain High

Hungary Holds Rates Steady As Inflation Expected To Remain High

The Hungarian central bank left its interest rates unchanged again, on Tuesday, as policymakers assessed that tight monetary conditions were needed amid forecast that inflation is set to remain beyond the tolerance level in the coming months.

RTTNews | 5時31分前

Bay Street Likely To Post New Highs

Bay Street Likely To Post New Highs

Canadian shares are likely to open on a firm note Tuesday morning with higher oil and bullion prices set to trigger buying in energy and materials sectors.

RTTNews | 8時58分前

Wall Street Likely To Open Flat

Wall Street Likely To Open Flat

Futures point to a somewhat flat start on Wall Street Tuesday morning. Data on manufacturing and services sector activity in the U.S. in the month of August, due after the opening bell, is likely to provide some direction to the market.

RTTNews | 9時38分前

利用規約 | プライバシー | サイトマップ | Site Map Calendar

© 2025 Myfxbook Ltd。全著作権所有。

ハイリスクの警告：外国為替取引にはハイリスクが伴っているので、全ての人に適しているとは限りません。レバレッジは、追加のリスクと損失のエクスポージャーを生み出します。外国為替取引を決定する前に、あなたの投資目的、経験レベル、リスク許容度を慎重に検討してください。初期投資の一部及びその全ての失う可能性があるので、必要最低限以上のお金は投資しないでください。外国為替取引に関連するリスクについては、自分自身で学んで質問がある場合は独立した財務や税務顧問に質問してください。データと情報は全て'そのままの形'で提供されます。それらは情報提供のみを目的としており、取引目的やアドバイスを目的としたものではありません。過去の実績は、将来の結果を示すものではありません。